Abstract
Complications due to uric acid used to be very common in malignancy. In one series of patients with leukemia, 25% had uric acid levels above 12 mg.% at some time during their disease1. Almost all complications related to uric acid excretion can be prevented. Although hyperuricemia may occur with any malignancy, the difficulties in children arise primarily in association with acute leukemia and lymphosarcoma.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
KRAKOFF, I. H. and MEYER, R. L.: Prevention of hyperuricemia in leukemia and lymphoma. JAMA, 193: I, 1965.
SINKS, L. E.. NEWTON, A. W.. Jr., NAGI, N. A. and STEVENSON, T. D.: A syndrome associated with extreme hyperuricemia in leukemia. J Pediair. 68: 578, 1966.
BAND, P. R., SILVERBERG, D. S. HENDERSON, J. E., ULAN, R. A., WENSEL, R. H, BANERJEE, T. K. and LITTLE, A. S.: Xanthine nephropathy in a patient with lymphosarcoma treated with allopurinol. N Engl J Med. 283: 354, 1970.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1973 Ontario Cancer Treatment and Research Foundation
About this chapter
Cite this chapter
Saunders, E.F. (1973). Uric Acid Metabolism in Malignancy. In: Godden, J.O. (eds) Cancer in Childhood. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-2070-8_36
Download citation
DOI: https://doi.org/10.1007/978-1-4684-2070-8_36
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-2072-2
Online ISBN: 978-1-4684-2070-8
eBook Packages: Springer Book Archive